BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26659720)

  • 21. Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung.
    Lee MS; Liu CY; Su L; Christiani DC
    Lung Cancer; 2015 Jul; 89(1):8-12. PubMed ID: 26001533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of the tumour-adjacent tissue in head and neck cancers.
    Raudenska M; Sztalmachova M; Gumulec J; Fojtu M; Polanska H; Balvan J; Feith M; Binkova H; Horakova Z; Kostrica R; Kizek R; Masarik M
    Tumour Biol; 2015 Dec; 36(12):9929-39. PubMed ID: 26168959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
    Wang X; Yin Z; Zhao Y; He M; Dong C; Zhong M
    Mol Med Rep; 2020 Mar; 21(3):1647-1657. PubMed ID: 32016476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. XPD, APE1, and MUTYH polymorphisms increase head and neck cancer risk: effect of gene-gene and gene-environment interactions.
    Das S; Bhowmik A; Bhattacharjee A; Choudhury B; Naiding M; Laskar AK; Ghosh SK; Choudhury Y
    Tumour Biol; 2015 Sep; 36(10):7569-79. PubMed ID: 25916209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HapMap-based study of the DNA repair gene ERCC2 and lung cancer susceptibility in a Chinese population.
    Yin J; Vogel U; Ma Y; Qi R; Wang H
    Carcinogenesis; 2009 Jul; 30(7):1181-5. PubMed ID: 19406934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of Mitochondrial Tumor Suppressor Genes Expression Is Associated with Unfavorable Clinical Outcome in Head and Neck Squamous Cell Carcinoma: Data from Retrospective Study.
    Mahjabeen I; Kayani MA
    PLoS One; 2016; 11(1):e0146948. PubMed ID: 26785117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of risk of squamous cell carcinoma head and neck in North Indian population with polymorphisms in xeroderma pigmentosum complementation Group C gene.
    Yadav SK; Singh S; Gupta S; Brahma Bhatt ML; Mishra DP; Roy D; Sanyal S
    J Cancer Res Ther; 2018; 14(3):651-657. PubMed ID: 29893334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA repair gene ERCC2 polymorphisms and risk of squamous cell carcinoma of the head and neck.
    Gugatschka M; Dehchamani D; Wascher TC; Friedrich G; Renner W
    Exp Mol Pathol; 2011 Aug; 91(1):331-4. PubMed ID: 21419115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia.
    Zhong W; Peng J; He H; Wu D; Han Z; Bi X; Dai Q
    Clin Invest Med; 2008; 31(1):E8-E15. PubMed ID: 18312749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
    Xiao F; Pu J; Wen Q; Huang Q; Zhang Q; Huang B; Huang S; Lan A; Zhang Y; Li J; Zhao D; Shen J; Wu H; He Y; Li H; Yang X
    Oncotarget; 2017 Jul; 8(29):48488-48506. PubMed ID: 28489582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal differentiation complex (locus 1q21) gene expression in head and neck cancer and normal mucosa.
    Tyszkiewicz T; Jarzab M; Szymczyk C; Kowal M; Krajewska J; Jaworska M; Fraczek M; Krajewska A; Hadas E; Swierniak M; Markowski J; Lange D; Poltorak S; Wiench M; Krecicki T; Jarzab J; Maciejewski A
    Folia Histochem Cytobiol; 2014; 52(2):79-89. PubMed ID: 25007175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleotide excision repair gene subunit XPD is highly expressed in cervical squamous cell carcinoma.
    Ye F; Jiao J; Zhou C; Cheng Q; Chen H
    Pathol Oncol Res; 2012 Oct; 18(4):969-75. PubMed ID: 22760492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis.
    Lu X; Xiao S; Jin C; van der Straaten T; Li X
    J Clin Lab Anal; 2012 Jan; 26(1):10-5. PubMed ID: 24833529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic analysis of differentially methylated expressed genes and site-specific methylation as potential prognostic markers in head and neck cancer.
    Bai G; Song J; Yuan Y; Chen Z; Tian Y; Yin X; Niu Y; Liu J
    J Cell Physiol; 2019 Dec; 234(12):22687-22702. PubMed ID: 31131446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review.
    Manuguerra M; Saletta F; Karagas MR; Berwick M; Veglia F; Vineis P; Matullo G
    Am J Epidemiol; 2006 Aug; 164(4):297-302. PubMed ID: 16707649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer.
    Geredeli C; Artac M; Yildirim S; Inal A; Dede I; Guler T; Boruban MC; Koral L; Karaagac M; Zamani AG; Altinok T; Aribas O; Bozcuk H; Demirkazik A
    Tumour Biol; 2015 Jun; 36(6):4279-85. PubMed ID: 25596702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ERCC2/XPD Lys751Gln polymorphism affects DNA repair of benzo[a]pyrene induced damage, tested in an in vitro model.
    Xiao S; Cui S; Lu X; Guan Y; Li D; Liu Q; Cai Y; Jin C; Yang J; Wu S; van der Straaten T
    Toxicol In Vitro; 2016 Aug; 34():300-308. PubMed ID: 27139774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity.
    Moisan F; Laroche-Clary A; Auzanneau C; Ricard N; Pourquier P; Robert J; Le Morvan V
    Carcinogenesis; 2012 May; 33(5):962-8. PubMed ID: 22345163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients.
    Schena M; Guarrera S; Buffoni L; Salvadori A; Voglino F; Allione A; Pecorari G; Ruffini E; Garzino-Demo P; Bustreo S; Consito L; Bironzo P; Matullo G
    DNA Repair (Amst); 2012 Apr; 11(4):374-80. PubMed ID: 22284908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive Value of ERCC1, ERCC2, and XRCC Expression for Patients with Locally Advanced or Metastatic Gastric Cancer Treated with Neoadjuvant mFOLFOX-4 Chemotherapy.
    Yeh YS; Chen YT; Tsai HL; Huang CW; Ma CJ; Su WC; Huang CM; Huang MY; Hu HM; Lu CY; Wang JY
    Pathol Oncol Res; 2020 Apr; 26(2):1105-1116. PubMed ID: 31077069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.